Old Web
English
Sign In
Acemap
>
authorDetail
>
John William Beadle
John William Beadle
Medicine
Proportional hazards model
Placebo
Nivolumab
Internal medicine
3
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
329 Prolonged overall survival (OS) in patients with metastatic colorectal cancer (mCRC) in SPICE, a phase I study of enadenotucirev in combination with nivolumab
2020
Journal for ImmunoTherapy of Cancer
Tom Lillie
Andrew Stone
Sarah Lockwood
Richard Brown
Andrew J. Fox
Eirini Bournazou
John William Beadle
Show All
Source
Cite
Save
Citations (0)
329 Prolonged overall survival (OS) in patients with metastatic colorectal cancer (mCRC) in SPICE, a phase I study of enadenotucirev in combination with nivolumab
2020
Journal for ImmunoTherapy of Cancer
Tom Lillie
Andrew Stone
Sarah Lockwood
Richard Brown
Andrew J. Fox
Eirini Bournazou
John William Beadle
Show All
Source
Cite
Save
Citations (0)
A first-in-class, first-in-human phase I study of enadenotucirev, an oncolytic Ad11/Ad3 chimeric group B adenovirus, administered intravenously in patients with metastatic epithelial tumors.
2014
Journal of Clinical Oncology
Emiliano Calvo
Marta Gil-Martin
Jean-Pascal Machiels
Sylvie Rottey
Antonio Cubillo
Ramon Salazar
Feby Ingriani Mardjuadi
Karen Geboes
Christopher Ellis
John William Beadle
Christine Blanc
Show All
Source
Cite
Save
Citations (11)
1